Ginkgo Bioworks Holdings Inc (DNA)
10.08
+1.34
(+15.33%)
USD |
NYSE |
Dec 20, 16:00
10.08
0.00 (0.00%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Profit Margin (Quarterly): -63.95% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Lexicon Pharmaceuticals Inc | -3.70K% |
| Atara Biotherapeutics Inc | -54.51% |
| Corvus Pharmaceuticals Inc | -- |
| Clearside Biomedical Inc | -740.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.54% |
| Return on Assets | -38.86% |
| Return on Invested Capital | -65.54% |
| Gross Profit Margin (Quarterly) | 86.39% |
| Operating Margin (Quarterly) | -60.20% |
| Return on Net Operating Assets | -96.57% |